Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 5Y returns in the bottom 25% of the category. | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 7/8 | 8/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 7 Years | 13 Years 8 Months | ||
Fund AUM | ₹950 Cr | ₹8636 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.84% | 0.79% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 40 | 37 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 96.83% | 97.92% | ||
Debt % | - | - | ||
P/E | 38.55 | 36.71 | ||
P/B | 5.7 | 5.41 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 2.01% | 1.75% | ||
3-Month Return | 11.95% | 10.33% | ||
6-Month Return | 12.25% | 8.38% | ||
1-Year Return | 15.2% | 8.74% | ||
3-Year Return | 24.76% | 22.62% | ||
5-Year Return | 14.81% | 13.86% |
Sharpe | 1.1 | 1.03 | ||
Alpha | 0.72 | -0.47 | ||
Beta | 0.92 | 0.9 | ||
Standard Deviation | 16.17 | 15.79 | ||
Information Ratio | -0.19 | -0.65 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah | Sailesh Raj Bhan, Amber Singhania, Kinjal Desai |

